HCPCS Level II drug code
J2794 — Injection, risperidone (risperdal consta), 0.5 mg
In short
J2794 is the HCPCS Level II code for injection, risperidone (risperdal consta), 0.5 mg. CMS assigns NDCs for Risperdal Consta and Risperidone ER to it. One billing unit is 0.5 mg. The Medicare Part B payment limit is $10.662 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Injection, risperidone (risperdal consta), 0.5 mg
- Short descriptor
- Inj risperdal consta, 0.5 mg
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Oct 1, 2019
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Units = dose given ÷ 0.5 mg. For example, 50 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
NDCs billed under J2794
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 14 NDCs to J2794 for Risperdal Consta and Risperidone ER. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Risperdal Consta | 50458-0306-11 | Janssen Pharmaceuticals, Inc. | 1 | 50 |
| Risperdal Consta | 50458-0307-11 | Janssen Pharmaceuticals, Inc. | 1 | 75 |
| Risperdal Consta | 50458-0308-11 | Janssen Pharmaceuticals, Inc. | 1 | 100 |
| Risperdal Consta | 50458-0309-11 | Janssen Pharmaceuticals, Inc. | 1 | 25 |
| Risperidone ER | 00480-1232-08 | Teva Pharmaceuticals USA, Inc. | 1 | 50 |
| Risperidone ER | 00480-1342-08 | Teva Pharmaceuticals USA, Inc. | 1 | 75 |
| Risperidone ER | 00480-1453-08 | Teva Pharmaceuticals USA, Inc. | 1 | 100 |
| Risperidone ER | 00480-1554-08 | Teva Pharmaceuticals USA, Inc. | 1 | 25 |
| Risperidone ER | 70121-2626-05 | Amneal Pharmaceuticals, LLC | 1 | 50 |
| Risperidone ER | 70121-2627-05 | Amneal Pharmaceuticals, LLC | 1 | 75 |
| Risperidone ER | 70121-2628-05 | Amneal Pharmaceuticals, LLC | 1 | 100 |
| Risperidone ER | 70748-0270-13 | Lupin Pharmaceuticals, Inc. | 1 | 50 |
| Risperidone ER | 70748-0271-13 | Lupin Pharmaceuticals, Inc. | 1 | 75 |
| Risperidone ER | 70748-0272-13 | Lupin Pharmaceuticals, Inc. | 1 | 100 |
J2794: common questions
- Is J2794 a CPT code?
- No. J2794 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J2794?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 14 NDCs under J2794, for Risperdal Consta and Risperidone ER. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J2794?
- $10.662 per 0.5 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
- What is one billing unit of J2794?
- One unit of J2794 is 0.5 mg, as stated in the code's descriptor. Units to report = dose given ÷ 0.5 mg. J-code billing units.